Swift Christopher 4
4 · HARTFORD INSURANCE GROUP, INC. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Hartford (HIG) CEO Christopher Swift Exercises Options and Sells Shares
What Happened
- Christopher Swift, Chairman & CEO of Hartford Insurance Group (HIG), exercised 201,938 stock options (exercise price $48.89; total exercise cost reported $9,872,749) on Feb 2, 2026, and on the same day sold the 201,938 resulting shares in multiple open-market transactions for total proceeds of approximately $27.55M.
- Sales were executed in several blocks at prices ranging roughly from $135.04 to $137.14 per share (individual blocks and proceeds listed below). The Form 4 also reports a derivative/conversion entry for 201,938 shares at $0.00 (recorded as a disposal).
Key Details
- Transaction date: Feb 2, 2026; Form filed Feb 4, 2026.
- Option exercise: 201,938 shares @ $48.89 = $9,872,749 (code M).
- Sales (code S), all on Feb 2, 2026:
- 7,598 sh @ $137.08 = $1,041,503
- 7,845 sh @ $137.09 = $1,075,433
- 19,734 sh @ $135.54 = $2,674,662
- 19,834 sh @ $135.56 = $2,688,755
- 73,390 sh @ $136.57 = $10,023,056
- 73,537 sh @ $136.58 = $10,043,529
- Total sold: 201,938 shares; total proceeds ≈ $27,546,938.
- A separate derivative entry lists 201,938 shares disposed at $0.00 (reported as exercise/conversion/disposition).
- Footnotes note the trades were executed under a Rule 10b5-1 trading plan adopted Nov 3, 2025; the exercised options were granted in 2017 and expire Feb 28, 2027.
- Beneficial ownership after the transaction is not specified in the provided excerpt.
- Filing appears timely (transactions 2/2/2026; Form filed 2/4/2026).
Context
- This is an option exercise (M) followed by immediate open-market sales (S) of the same number of shares — a common pattern when executives exercise vested options and sell shares (often to cover exercise costs, taxes, or for diversification). The presence of a pre-established 10b5-1 plan indicates the sales were executed under a pre-set program, not necessarily a reactive trade.
- Transaction codes: M = option exercise/conversion; S = sale. The $0.00 derivative disposal entry reflects how the exercise/conversion was reported on the Form 4, per the filing.
Insider Transaction Report
Form 4
Swift Christopher
DirectorChairman and CEO
Transactions
- Exercise/Conversion
Common Stock
2026-02-02$48.89/sh+201,938$9,872,749→ 396,754.948 total - Sale
Common Stock
[F1][F2]2026-02-02$137.08/sh−7,598$1,041,503→ 389,156.948 total - Sale
Common Stock
[F1][F3]2026-02-02$137.09/sh−7,845$1,075,433→ 381,311.948 total - Sale
Common Stock
[F1][F4]2026-02-02$135.54/sh−19,734$2,674,662→ 361,577.948 total - Sale
Common Stock
[F1][F5]2026-02-02$135.56/sh−19,834$2,688,755→ 341,743.948 total - Sale
Common Stock
[F1][F6]2026-02-02$136.57/sh−73,390$10,023,056→ 268,353.948 total - Sale
Common Stock
[F1][F6]2026-02-02$136.58/sh−73,537$10,043,529→ 194,816.948 total - Exercise/Conversion
Stock Option
[F7]2026-02-02−201,938→ 100,970 totalExercise: $48.89Exp: 2027-02-28→ Common Stock (201,938 underlying)
Holdings
- 40,003(indirect: By Spouse)
Common Stock
- 95,386(indirect: By Trust)
Common Stock
- 60,865(indirect: By Trust)
Common Stock
- 352,263
Stock Option
[F8]Exercise: $49.01Exp: 2029-02-26→ Common Stock (352,263 underlying) - 310,820
Stock Option
[F9]Exercise: $51.87Exp: 2031-02-23→ Common Stock (310,820 underlying) - 284,819
Stock Option
[F10]Exercise: $53.81Exp: 2028-02-27→ Common Stock (284,819 underlying) - 327,679
Stock Option
[F11]Exercise: $55.27Exp: 2030-02-25→ Common Stock (327,679 underlying) - 301,932
Stock Option
[F12]Exercise: $69.41Exp: 2032-02-23→ Common Stock (301,932 underlying) - 248,933
Stock Option
[F13]Exercise: $78.28Exp: 2033-02-28→ Common Stock (248,933 underlying) - 116,414
Stock Option
[F14]Exercise: $95.74Exp: 2034-02-27→ Common Stock (116,414 underlying) - 99,403
Stock Option
[F15]Exercise: $116.41Exp: 2035-02-25→ Common Stock (99,403 underlying)
Footnotes (15)
- [F1]The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2017 and are scheduled to expire on February 28, 2027.
- [F10]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
- [F11]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
- [F12]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
- [F13]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
- [F14]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- [F15]One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- [F2]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.14 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.13 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.89 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.93 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $136.04 - $137.03 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F7]The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
- [F8]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
- [F9]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact|2026-02-04